Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte that plays a crucial role in nerve impulse transmission, muscle contraction, and maintaining acid-base balance. It is primarily used to treat or prevent hypokalemia. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, especially in patients receiving diuretics that cause potassium loss. ## Adult Dosing * **Treatment of Hypokalemia:** * Oral: Typically 20-100 mEq per day in divided doses. May require higher doses in severe deficiency. * Intravenous (IV): Usually 20-40 mEq per day. In severe hypokalemia or when oral administration is not feasible, doses up to 100-120 mEq per day can be administered, but this requires very careful cardiac monitoring. * **Maximum infusion rate (IV):** Generally 10-20 mEq/hour peripherally, and up to 40 mEq/hour centrally, but rates up to 100 mEq/hour may be used in life-threatening situations with continuous ECG monitoring. * **Maximum concentration (IV):** Typically 40 mEq/L peripherally; higher concentrations (up to 100 mEq/L) may be used centrally with caution. * **Prevention of Hypokalemia:** * Oral: Typically 20-40 mEq per day. *Note: Specific dosing often depends on serum potassium levels, severity of deficit, and individual patient factors. Local protocols may dictate maximum doses and infusion rates, particularly for IV administration.* ## Pediatric Dosing * **Treatment of Hypokalemia:** * Oral: 1-2 mEq/kg/day divided into 2-4 doses. Maximum daily dose generally 20-40 mEq. * Intravenous (IV): 0.5-1 mEq/kg per dose, up to 20 mEq per dose. Maximum daily dose is typically 40-100 mEq, depending on severity and monitoring. * **Maximum infusion rate (IV):** Generally 0.5-1 mEq/kg/hour, not to exceed 10 mEq/hour. * **Maximum concentration (IV):** Typically 40 mEq/L peripherally. *Note: Pediatric dosing is highly individualized and requires close monitoring. Consult pediatric-specific guidelines or consult a pediatric specialist.* ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium excretion is reduced in renal impairment. Dosing adjustments are critical, and lower doses or avoidance may be necessary. Monitor serum potassium closely. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia, such as Addison's disease, untreated Addison's disease, anuria, severe renal impairment, or during the immediate post-operative period in patients with renal insufficiency. * Certain medications that increase serum potassium (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics) may necessitate dose reduction or increased monitoring. ## Adverse Effects * **Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), especially with oral administration. * **Serious:** Hyperkalemia (symptoms include paresthesias, muscle weakness, flaccid paralysis, cardiac arrhythmias, cardiac arrest), especially with rapid IV infusion or in patients with impaired renal function. Esophageal or gastrointestinal ulceration and bleeding can occur with sustained-release oral formulations if not taken with sufficient fluid or if there is GI motility impairment. ## Key Drug Interactions * **ACE Inhibitors, ARBs, Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **NSAIDs:** May impair potassium excretion, increasing the risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the risk of digoxin toxicity. Hypokalemia can increase the risk of digoxin toxicity. * **Anticholinergics:** May impair GI motility, potentially increasing the risk of GI irritation with oral potassium. ## Monitoring * Serum potassium levels are essential. * Renal function (BUN, creatinine). * ECG monitoring is crucial for IV potassium administration, especially at higher doses or infusion rates, and in patients with cardiac disease or suspected hyperkalemia. * Monitor for signs and symptoms of hypokalemia or hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with meals and a full glass of water to minimize GI irritation. * Do not crush or chew sustained-release formulations. * IV potassium is a vesicant and must be administered carefully to avoid extravasation, which can cause tissue damage. * Rapid IV infusion of potassium is dangerous and should only be done in dire emergencies with continuous cardiac monitoring. * Consider the total daily potassium intake from all sources, including diet and other medications. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date information before making any treatment decisions.